Pembro/Carbo/Taxol in Endometrial Cancer

NCT02549209 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Endometrial Adenocarcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Daniela Matei, MD

Collaborators

[object Object]
[object Object]